| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.2 | 0.0001 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.18 | 0.0002 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |